Dr Reddys Laboratories Share Price Today - Live Blog for July 07, 2025

The share price of Dr Reddys Laboratories Ltd plunged by -0.18%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,308.20, but investors are assessing whether this is a temporary dip or a long-term trend.

Dr Reddys Laboratories Ltd's share price has fallen by -0.11%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,309.30, and market participants are assessing the implications. The stock has a PE ratio of 19.2600, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.06% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,310.75 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd share price has declined by -0.18%, and it's currently trading at ₹1,309.70. The stock maintains a PE of 19.2600, while the industry PE is 35.3587, prompting discussions about its valuation.

With a remarkable 0.05% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,310.70. Notably, this stock has a Price-to-Earnings (PE) ratio of 19.2600, while the industry's PE ratio is 35.3587.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.16% gain, with the share price now at ₹1,310.00. Notably, the stock's PE ratio stands at 19.2600, and its Return on Equity (ROE) is 16.8559%.

Dr Reddys Laboratories Ltd witnessed a -0.02% decrease in its share price, and it is currently trading at ₹1,309.05. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 19.2600, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd plunged by -0.09%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,307.00, but investors are assessing whether this is a temporary dip or a long-term trend.

Dr Reddys Laboratories Ltd share price has declined by -0.05%, and it's currently trading at ₹1,308.25. The stock maintains a PE of 19.2600, while the industry PE is 35.3587, prompting discussions about its valuation.

Dr Reddys Laboratories Ltd's stock price surged by 0.09%, reaching the current market value of ₹1,306.95 per share. This surge is a testament to the stock's recent performance.

Dr Reddys Laboratories Ltd's stock has surged by 0.05%, and it is currently trading at ₹1,304.95. Additionally, the stock maintains a PE ratio of 19.2600, while the industry PE is 35.3587.

Dr Reddys Laboratories Ltd shares experienced a -0.00% reduction, with the current market price at ₹1,304.35. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.13%. At this moment, it's actively trading at ₹1,304.40, presenting an enticing opportunity for those in the market.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.03% upswing, and it's currently trading at ₹1,302.75 per share. Investors are closely watching this development.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.02%, signalling a challenging period. Currently trading at ₹1,301.90, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Dr Reddys Laboratories Ltd shares experienced a -0.30% reduction, with the current market price at ₹1,302.90. Investors are carefully considering their positions and seeking insights into the stock's future performance.

After a significant 0.06% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,306.80 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Dr Reddys Laboratories Ltd's share price has fallen by -0.23%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,305.45, and market participants are assessing the implications. The stock has a PE ratio of 19.2600, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Demonstrating a commendable 0.08% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,308.45. In terms of valuation, the stock maintains a PE ratio of 19.2600, while the industry PE ratio stands at 35.3587.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.10%. At this moment, it's actively trading at ₹1,307.35, presenting an enticing opportunity for those in the market.

Following a noteworthy 0.37% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,306.05. When it comes to valuation, this stock has a PE ratio of 19.2600, with the industry PE ratio at 35.3587.

Dr Reddys Laboratories Ltd experienced a -0.07% downturn in its share price, and it's currently trading at ₹1,301.30. This situation is generating interest among value investors who are evaluating the stock's potential.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.05%, and as of now, it's trading at ₹1,302.15 per share. This upward trajectory is attracting keen interest from investors.

The share price of Dr Reddys Laboratories Ltd plunged by -0.33%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,301.50, but investors are assessing whether this is a temporary dip or a long-term trend.

Dr Reddys Laboratories Ltd shares saw a -0.23% decrease, reaching a current market price of ₹1,305.60. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 19.2600, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's shares experienced a 0.27% uptick, and they are currently valued at ₹1,308.60, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.